Tennivalók az immun eredetü heparin indukált thrombocytopeniában.

Translated title of the contribution: Clinical aspects of heparin induced thrombocytopenia

Research output: Contribution to journalArticle

Abstract

Heparin induced thrombocytopenia has remained the major complication of therapy or prophylaxis with heparin. Although low molecular weight heparins seem to confer much lesser chance to induce thrombocytopenia, the danger is still considerable, and the fatal outcome is not rare. A lot of new data have been published about the origin, binding, physicochemical properties of the antibodies, the responsive platelet membrane receptors, and laboratory diagnosis in particular, however, many issues are still unresolved. The anticoagulant treatment of cases, in which heparin induced thrombocytopenia in associated with progressive, frequently arterial thrombosis still needs great skills, experience and the use of new generation antithrombotic agents. This review summarizes briefly the internationally accepted standard diagnostic and therapeutic protocols with heparin induced thrombocytopenia.

Original languageHungarian
Pages (from-to)1667-1671
Number of pages5
JournalOrvosi Hetilap
Volume140
Issue number30
Publication statusPublished - Jul 25 1999

Fingerprint

Thrombocytopenia
Heparin
Fibrinolytic Agents
Fatal Outcome
Clinical Laboratory Techniques
Low Molecular Weight Heparin
Anticoagulants
Thrombosis
Blood Platelets
Membranes
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tennivalók az immun eredetü heparin indukált thrombocytopeniában. / Udvardy, M.; Boda, Z.; Rák, K.

In: Orvosi Hetilap, Vol. 140, No. 30, 25.07.1999, p. 1667-1671.

Research output: Contribution to journalArticle

@article{51d8ec5f4ffd4ea88801e252fda527d9,
title = "Tennival{\'o}k az immun eredet{\"u} heparin induk{\'a}lt thrombocytopeni{\'a}ban.",
abstract = "Heparin induced thrombocytopenia has remained the major complication of therapy or prophylaxis with heparin. Although low molecular weight heparins seem to confer much lesser chance to induce thrombocytopenia, the danger is still considerable, and the fatal outcome is not rare. A lot of new data have been published about the origin, binding, physicochemical properties of the antibodies, the responsive platelet membrane receptors, and laboratory diagnosis in particular, however, many issues are still unresolved. The anticoagulant treatment of cases, in which heparin induced thrombocytopenia in associated with progressive, frequently arterial thrombosis still needs great skills, experience and the use of new generation antithrombotic agents. This review summarizes briefly the internationally accepted standard diagnostic and therapeutic protocols with heparin induced thrombocytopenia.",
author = "M. Udvardy and Z. Boda and K. R{\'a}k",
year = "1999",
month = "7",
day = "25",
language = "Hungarian",
volume = "140",
pages = "1667--1671",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "30",

}

TY - JOUR

T1 - Tennivalók az immun eredetü heparin indukált thrombocytopeniában.

AU - Udvardy, M.

AU - Boda, Z.

AU - Rák, K.

PY - 1999/7/25

Y1 - 1999/7/25

N2 - Heparin induced thrombocytopenia has remained the major complication of therapy or prophylaxis with heparin. Although low molecular weight heparins seem to confer much lesser chance to induce thrombocytopenia, the danger is still considerable, and the fatal outcome is not rare. A lot of new data have been published about the origin, binding, physicochemical properties of the antibodies, the responsive platelet membrane receptors, and laboratory diagnosis in particular, however, many issues are still unresolved. The anticoagulant treatment of cases, in which heparin induced thrombocytopenia in associated with progressive, frequently arterial thrombosis still needs great skills, experience and the use of new generation antithrombotic agents. This review summarizes briefly the internationally accepted standard diagnostic and therapeutic protocols with heparin induced thrombocytopenia.

AB - Heparin induced thrombocytopenia has remained the major complication of therapy or prophylaxis with heparin. Although low molecular weight heparins seem to confer much lesser chance to induce thrombocytopenia, the danger is still considerable, and the fatal outcome is not rare. A lot of new data have been published about the origin, binding, physicochemical properties of the antibodies, the responsive platelet membrane receptors, and laboratory diagnosis in particular, however, many issues are still unresolved. The anticoagulant treatment of cases, in which heparin induced thrombocytopenia in associated with progressive, frequently arterial thrombosis still needs great skills, experience and the use of new generation antithrombotic agents. This review summarizes briefly the internationally accepted standard diagnostic and therapeutic protocols with heparin induced thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=0033603655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033603655&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 1667

EP - 1671

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 30

ER -